Home › Borstkanker › Virginia › Richmond
Borstkanker klinische studies in Richmond, VA
26 studies voor Borstkanker zoeken deelnemers op locaties in en rond Richmond (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruterenGezonde vrijwilligers welkom
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekruterenFase 3
- Bon Secours Virginia Health System, Midlothian · 11 mijl verwijderd
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- en nog 3
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RekruterenFase 2
- Virginia Cancer Institute, Richmond
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekruterenFase 3
- VCU Health Adult Outpatient Pavillion ( Site 0070), Richmond
- Bon Secours St. Francis Medical Center-Oncology Research ( Site 0015), Midlothian · 11 mijl verwijderd
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruterenFase 3
- Research Site, Midlothian · 11 mijl verwijderd
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruterenFase 3
- Bon Secours Cancer Institute at St. Francis ( Site 0048), Midlothian · 11 mijl verwijderd
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekruterenFase 3
- Clinical Trial Site, Midlothian · 11 mijl verwijderd
Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
Rekruteren
- Adult Outpatient Pavilion, Richmond
- Cellular Immunotherapies and Transplant Department, Richmond
- VCU Health at Stony Point, Richmond
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruterenFase 3
- Bon Secours Cancer Institute at St. Mary's, Richmond
- Bon Secours Cancer Institute at Memorial Regional, Mechanicsville · 6 mijl verwijderd
- Bon Secours St. Francis Medical Center, Midlothian · 11 mijl verwijderd
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- Virginia Cancer Institute, Richmond
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RekruterenFase 3
- Research Site, Midlothian · 11 mijl verwijderd
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- en nog 4
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekruterenFase 2/3
- Bon Secours St. Francis Medical Center, Midlothian · 11 mijl verwijderd
E-Mindfulness Approaches for Living After Breast Cancer
RekruterenFase 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Virginia Cancer Institute, Richmond
- en nog 4
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Rekruteren
- Virgina Community University Massey Comprehensive Cancer Center, Richmond
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation
RekruterenFase 1
- Virginia Commonwealth University, Richmond
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
RekruterenFase 3
- Virginia Commonwealth University, Richmond
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
RekruterenFase 3
- Bon Secours St. Francis Medical Oncology Center, Midlothian · 11 mijl verwijderd
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruterenFase 3
- Bon Secours Cancer Institute at Memorial Regional Medical Center, Mechanicsville · 6 mijl verwijderd
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruterenFase 3
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- Bon Secours Memorial Regional Medical Center, Mechanicsville · 6 mijl verwijderd
- en nog 1
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruterenObservatieonderzoek
- VCU Massey Cancer Center at Stony Point, Richmond
- Virginia Commonwealth University/Massey Cancer Center, Richmond
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
RekruterenObservatieonderzoek
- VCU Massey Comprehensive Cancer Center, Richmond
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekruterenObservatieonderzoek
- VCU Massey Comprehensive Cancer Center, Richmond
- Bon Secours Cancer Institute at St. Francis, Midlothian · 11 mijl verwijderd
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
RekruterenFase 2
- Virginia Commonwealth University, Richmond
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
RekruterenGezonde vrijwilligers welkom
- Virginia Commonwealth University, Richmond
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in Richmond
- Niet-kleincellige longkanker25 studies
- Prostaatkanker19 studies
- Hartfalen16 studies
- Longkanker14 studies
- Cardiovasculaire ziekte13 studies
- Colorectale kanker13 studies
- Steatotische leveraandoening12 studies
- Acute myeloïde leukemie12 studies
- Metastatische kanker12 studies
- Plaveiselcelcarcinoom van hoofd en hals12 studies
- Melanoom11 studies
- Obesitas11 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.